RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Yohannes Tesfaigzi to Matrix Metalloproteinase 9

This is a "connection" page, showing publications Yohannes Tesfaigzi has written about Matrix Metalloproteinase 9.
  1. Tesfaigzi Y, Myers OB, Stidley CA, Schwalm K, Picchi M, Crowell RE, Gilliland FD, Belinsky SA. Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chron Obstruct Pulmon Dis. 2006; 1(3):267-78.
    View in: PubMed
    Score: 0.266
  2. Tesfaigzi Y, Myers OB, Stidley CA, Schwalm K, Picchi M, Crowell RE, Gilliland FD, Belinsky SA. Genotypes in matrix metalloproteinase 9 are risk factors for chronic obstructive pulmonary disease. Exp Lung Res. 2005 Sep; 31 Suppl 1:74-5.
    View in: PubMed
    Score: 0.260
  3. Wang X, Rojas-Quintero J, Wilder J, Tesfaigzi Y, Zhang D, Owen CA. Tissue Inhibitor of Metalloproteinase-1 Promotes Polymorphonuclear Neutrophil (PMN) Pericellular Proteolysis by Anchoring Matrix Metalloproteinase-8 and -9 to PMN Surfaces. J Immunol. 2019 06 01; 202(11):3267-3281.
    View in: PubMed
    Score: 0.167
  4. Nyunoya T, March TH, Tesfaigzi Y, Seagrave J. Antioxidant diet protects against emphysema, but increases mortality in cigarette smoke-exposed mice. COPD. 2011 Oct; 8(5):362-8.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support